We connect industry and government with UNC scientists and technologies to establish research collaborations with the goal of developing and commercializing innovations.

  • Search Available Technologies invented by faculty at the UNC Eshelman School of Pharmacy for licensing opportunities
  • Explore Faculty Expertise for:
    • collaboration, contract research, and licensing opportunities
    • consulting related to drug discovery-development and regulatory issues

Pharmacometrics Core

Julie Dumond, Director

UNC Center for Aids Research Clinical Pharmacology & Analytical Chemistry Core

Angela Kashuba, Director

NC Cancer Hospital Clinical Pharmacology Lab

Chris Walko, Director

GLP Bioanalytical Facility

Bill Zamboni, Director
John Kagel, Associate Director

UNC Metabolomics Laboratory

Jeff Macsdonals, Director

Cellular Metabolism and Transport Core

Phillip Smith, Director

The UNC Eshelman School of Pharmacy makes available several semester-long courses to industry scientists. These are graduate-level courses that provide an opportunity for industry professionals to stay abreast of cutting-edge science in areas such as formulation and drug delivery, nanomedicine, drug metabolism and transport, and pharmacokinetics.

The School has a state-of-the-art video teleconferencing facilities and considerable experience in delivering education to students at remote sites in an interactive environment. The courses are taught synchronously to the graduate students and postdoctoral trainees in class and to industry scientists at remote locations. Syllabi of courses that are available to industry scientists are provided below. Please contact Dhiren Thakker ( for any inquiry regarding these courses.

MOPH 738: Nanomedicine

Introduction to the interdisciplinary field of nanomedicine.

DPET 855: Pharmacokinetics

Principles of pharmacokinetics systems and techniques.

MOPH 810: Drug Metabolism

Contemporary techniques in drug metabolism, and clinical relevance of metabolic processes in the design and development of safe and efficacious drugs.

MOPH 862: Advanced Pharmaceutics

Discussion of physicochemical principles involved in drug delivery systems development.

MOPH 864: Advances in Drug Delivery

Discuss basic physicochemical and transport properties of the drug with emphasis in macromolecular drugs and drug carriers.

Carolina Center of Cancer Nanotechnology Excellence

C-CCNE focuses on improving cancer disease control and management with exciting new and cutting edge nanotechnologies to enhance treatment and early detection of cancer.

Center for Integrative Chemical Biology and Drug Discovery

The CICBDD brings dedicated medicinal chemistry expertise to bear on biological targets of therapeutic relevance under investigation by UNC faculty.

Center for Nanotechnology in Drug Delivery

The mission of the CNDD is to safely and effectively translate new drug and imaging discoveries into clinical trials using nanotechnology with the goal to improve human health.

Center for Pharmacogenomics and Individualized Therapy

The institute brings together researchers and clinicians across the University to create personalized therapies and treatments for patients suffering from a wide variety of conditions.

The Hamner-UNC Institute for Drug Safety Sciences

The Institute is dedicated to improving the safety evaluations at every stage in the life cycle of drugs.

Nanotechnology & Drug Delivery

BTM Nanocapsules and Nanoemulsions for Formulations of Drugs 
By Russell Mumper

Acoustic Measurement and Control of Pharmaceutical Sprays 
By Anthony Hickey

Coated Wire for Evaporation/Condensation Aerosol Generation of Therapeutic Agents 
By Anthony Hickey

Targeted Intracellular Delivery of Therapeutic Oligonucleotides 
By Rudolph Juliano

Increasing absorption of hydrophilic drugs by phospholipase C inhibition 
By Dhiren Thakker

Pharmaceutical Therapeutics – Cancer

Novel 4-amino-2H-benzo[h]chromen-2-one analogs (ABO), as Potent Anti-Cancer Agents 
By Kuo-Hsiung Lee

Antofine Derivatives, A New Class of Anti-Cancer Agents 
By Kuo-Hsiung Lee

Neo-Tanshinlactone and Analogs as Potent and Selective Anti-Breast Cancer Agents 
By Kuo-Hsiung Lee

Novel Tylophorine Analogs as a New Class of Anti-tumor Agents 
By Kuo-Hsiung Lee

Activatable Therapeutic Radionuclides for Cancer Treatment 
By Michael Jay

Pharmaceutical Therapeutics – Infectious Diseases

Novel 3,28-Disubstituted Betulinic Acid Derivatives as Potent Anti-HIV Agents 
By Kuo-Hsiung Lee

Novel Anti-HIV Tigliane-type Diterpenes 
By Kuo-Hsiung Lee


Enzymatic Approach to Synthesize Ultra Low Molecular Weight (ULMW) Heparins 
By Jian Liu

Therapeutic Targets for Herpes Simplex Viral Infection and Anticoagulation 
By Jian Liu

Inhibiting Pathogen Transport and Infection using Compositions and Antibodies Capable of Trapping Pathogens in Mucus 
By Sam Lai

Research Reagents/Methodology/Tools

Method for the Separation of Five Different Esters of DPTA 
By Michael Jay

Acylhydrazone-Based Cleavable Linkers 
By Harold Kohn

Fluorogenic Sensor of Mammalian Phosphatidylinositol-Specific Phospholipase C 
By Qisheng Zhang

Encapsulated Microbubbles to Process Biological Samples 
By William Janzen

Transfection of Immune Cells for Targeted Treatment of Disorders and Diseases 
By Alexander Kabanov


Improved Industrial Biocatalysts 
By Dhiren Thakker

If you would like to learn more about these technologies please contact:

UNC Office of Technology Development

Additional Resources:

School Fast Facts

For more information contact:

The Office of Entrepreneurial Development

thakkerDhiren Thakker, PhD

Associate Dean, Global Engagement
Ferguson Distinguished Professor and Director of Entrepreneurial Development


Laura Tollini, PhD

Innovation and Entrepreneurship Fellow
(919) 962-4898


Zawadi Barskile

Administrative Support Specialist
(919) 966-7658


Oleg  Kolupaev, PhD

Innovation and Entrepreneurship Intern